Denali Therapeutics Inc. is a biotechnology company focused on discovering and developing therapeutic interventions for neurodegenerative diseases. The primary aim of the company is to combat disorder... Denali Therapeutics Inc. is a biotechnology company focused on discovering and developing therapeutic interventions for neurodegenerative diseases. The primary aim of the company is to combat disorders linked to degeneration of the nervous system, such as Alzheimer's, Parkinson's, and ALS, by targeting and addressing underlying mechanisms of these diseases. Denali Therapeutics employs a unique engineering-driven approach, leveraging its deep understanding of biological pathways to create therapies that can cross the blood-brain barrier, an essential obstacle in the treatment of central nervous system diseases. Based in South San Francisco, California, Denali Therapeutics is at the forefront of the biotech industry, collaborating with research institutions and other pharmaceutical companies to advance its pipeline of potential treatments. Its work is pivotal in addressing unmet medical needs related to neurodegeneration, positioning the company as an important player in the pursuit of innovative healthcare solutions aimed at improving the quality of life for affected patients.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Greenhouse Gas (GHG) Emissions data disclosed by Denali Therapeutics

We reviewed Denali Therapeutics's website and available disclosure materials for the 2023 reporting period and did not identify any reported Greenhouse Gas (GHG) Emissions data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Denali Therapeutics's data?

Create a free Tracenable account to signal interest in having our team review data for Denali Therapeutics.

Legal Center Contact Us